article thumbnail

Here It Goes, Here It Goes, Here It Goes Again: The Build Back Better Act (Redux)

FDA Law Blog

With 190 pages dedicated to prescription drug pricing reform, the program is ambitious…and complicated. As a threshold matter, the 2-year delay provision does not solve the core problem for biosimilars manufacturers: the lack of predictability that Build Back Better injects into biosimilar development.

IT 52
article thumbnail

Interdisciplinary Case Report

CDOCS

The possible complications were communicated so that the patient could make an informed decision and proceed with treatment. I utilized 2CC of the mineralized freeze-dried allograft, particle size 500um to 1000um. I chose to utilize a zirconia abutment and selected shade 20 used for midrange shades in the VITA shade guide, i.e. A2.